Esperion Therapeutics
ESPR
ESPR
44 hedge funds and large institutions have $53.2M invested in Esperion Therapeutics in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$9.3M | |
| 2 | +$8.13M | |
| 3 | +$3.63M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.41M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$2.24M |
Top Sellers
| 1 | -$1.02M | |
| 2 | -$924K | |
| 3 | -$916K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$66.3K |